HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 5 - 12)

The Second to Fourth Digit (2d:4d) Ratios in Patients with Heroin Use Disorder

Canan F., Sogucak S., Karaca S., Tegin C., Gecici O., and Kuloglu M.

Summary: Background: The ratio between the length of the second and fourth fingers (2D:4D ratio) has been linked with prenatal testosterone concentrations, but also with alcohol and tobacco misuse. Aim: We aimed to investigate any possible association between 2D:4D ratios and heroin use disorder, and whether such a relationship might be independent of impulsivity. Methods: A group of 150 men with heroin use disorder, consecutively admitted to a detoxification and therapy unit, completed the Barratt Impulsiveness Scale-version 11 (BIS-11) and had their 2D:4D ratios measured, along with a group of 266 male controls of similar age and education. Results: Men with heroin use disorder had lower 2D:4D ratios on their right hand when compared with those without heroin use disorder. Results from logistic regression indicated that 2D:4D ratios were not significant independent predictors of heroin use disorder when attentional and non-planning impulsivity were considered. Conclusions: These findings suggest that high prenatal testosterone levels, as measured indirectly by 2D:4D ratios, are not independently associated with heroin use disorder among males.

 

EUROPAD - European Opiate Addiction Treatment Association
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page